Ambalal Sarabhai Enterprises Ltd

Ambalal Sarabhai Enterprises Ltd

₹ 35.9 -2.55%
06 Jun 3:14 p.m.
About

Incorporated in 1977, Ambalal Sarabhai Enterprises Ltd is in the business of manufacturing Pharmaceuticals and Electronics[1]

Key Points

Business Overview:[1]
ASE is a pharmaceutical health care companies, which through its group companies, manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and abroad

  • Market Cap 275 Cr.
  • Current Price 35.9
  • High / Low 77.7 / 34.1
  • Stock P/E 35.8
  • Book Value 6.33
  • Dividend Yield 0.00 %
  • ROCE 14.8 %
  • ROE 17.3 %
  • Face Value 10.0

Pros

  • Company has reduced debt.

Cons

  • Stock is trading at 5.70 times its book value
  • Promoter holding is low: 31.4%
  • Tax rate seems low
  • Company has a low return on equity of 12.6% over last 3 years.
  • Earnings include an other income of Rs.15.8 Cr.
  • Working capital days have increased from 384 days to 801 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
0.13 1.19 0.93 1.22 0.37 1.70 0.80 0.33 0.99 1.14 0.00 1.17 1.73
1.65 2.63 2.24 2.34 1.66 4.84 2.13 1.96 1.64 2.41 1.80 3.74 3.43
Operating Profit -1.52 -1.44 -1.31 -1.12 -1.29 -3.14 -1.33 -1.63 -0.65 -1.27 -1.80 -2.57 -1.70
OPM % -1,169.23% -121.01% -140.86% -91.80% -348.65% -184.71% -166.25% -493.94% -65.66% -111.40% -219.66% -98.27%
-8.19 2.37 1.99 2.79 2.60 1.18 1.96 1.33 3.41 1.88 6.37 10.81 -3.21
Interest 0.13 0.03 0.01 0.02 0.05 0.03 0.04 0.06 0.07 0.09 0.09 0.10 0.05
Depreciation 0.05 0.04 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.02
Profit before tax -9.89 0.86 0.63 1.62 1.23 -2.02 0.56 -0.39 2.66 0.49 4.45 8.12 -4.98
Tax % 5.36% 1.16% 17.46% 0.00% 8.94% 0.00% 0.00% 69.23% -76.32% 6.12% 3.15% -3.82% -0.40%
-10.42 0.86 0.52 1.62 1.12 -2.02 0.56 -0.65 4.70 0.46 4.31 8.43 -4.96
EPS in Rs -1.36 0.11 0.07 0.21 0.15 -0.26 0.07 -0.08 0.61 0.06 0.56 1.10 -0.65
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
15.67 15.25 6.98 1.51 0.92 0.00 0.00 0.00 0.13 3.71 3.81 4.04
29.02 27.30 28.62 14.47 21.76 8.86 7.86 11.69 5.71 8.87 8.61 11.37
Operating Profit -13.35 -12.05 -21.64 -12.96 -20.84 -8.86 -7.86 -11.69 -5.58 -5.16 -4.80 -7.33
OPM % -85.19% -79.02% -310.03% -858.28% -2,265.22% -4,292.31% -139.08% -125.98% -181.44%
3.43 14.17 95.94 -0.63 24.49 6.46 24.61 3.16 9.47 9.75 7.89 15.85
Interest 9.12 7.91 1.99 2.62 1.05 0.62 0.46 0.56 0.25 0.11 2.16 0.34
Depreciation 1.52 3.36 14.62 2.45 0.42 0.40 0.39 0.38 0.19 0.15 0.12 0.10
Profit before tax -20.56 -9.15 57.69 -18.66 2.18 -3.42 15.90 -9.47 3.45 4.33 0.81 8.08
Tax % 0.00% 0.00% 20.80% 10.18% 166.06% 13.45% 2.20% -0.84% 14.49% 5.31% -217.28% -1.98%
-20.57 -9.15 45.68 -20.57 -1.44 -3.88 15.55 -9.39 2.96 4.11 2.58 8.24
EPS in Rs -2.68 -1.19 5.96 -2.68 -0.19 -0.51 2.03 -1.23 0.39 0.54 0.34 1.08
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -12%
5 Years: %
3 Years: 214%
TTM: 6%
Compounded Profit Growth
10 Years: 9%
5 Years: -13%
3 Years: 31%
TTM: 198%
Stock Price CAGR
10 Years: 26%
5 Years: 18%
3 Years: 1%
1 Year: -18%
Return on Equity
10 Years: -10%
5 Years: 8%
3 Years: 13%
Last Year: 17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 76.63 76.63 76.63 76.63 76.63 76.63 76.63 76.63 76.63 76.63 76.63 76.63
Reserves -64.34 -73.49 -27.80 -46.41 -47.98 -51.85 -36.39 -45.85 -42.93 -38.79 -36.34 -28.14
27.27 30.10 29.54 22.13 11.07 11.07 11.00 11.14 9.77 11.49 10.03 7.66
97.45 103.24 65.13 63.81 91.28 102.78 73.35 58.14 39.53 30.42 30.96 26.77
Total Liabilities 137.01 136.48 143.50 116.16 131.00 138.63 124.59 100.06 83.00 79.75 81.28 82.92
46.41 42.66 20.60 16.43 14.98 14.65 14.48 13.97 13.00 12.86 12.84 12.22
CWIP 0.10 0.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 56.16 56.29 82.91 76.19 55.88 55.97 56.43 26.58 25.54 25.54 25.39 25.34
34.34 37.43 39.99 23.54 60.14 68.01 53.68 59.51 44.46 41.35 43.05 45.36
Total Assets 137.01 136.48 143.50 116.16 131.00 138.63 124.59 100.06 83.00 79.75 81.28 82.92

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1.43 -12.05 -69.37 -3.67 -12.66 -3.27 -4.53 -10.42 -7.79 1.52 -3.82 -4.08
2.34 12.70 75.22 8.64 26.14 2.37 4.92 15.76 20.77 0.61 3.48 6.35
-4.00 -0.75 -2.56 -8.14 -12.15 -0.44 -0.42 -0.32 -16.46 -3.76 0.30 -2.31
Net Cash Flow -0.23 -0.10 3.30 -3.17 1.33 -1.33 -0.03 5.02 -3.47 -1.63 -0.04 -0.04

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 78.26 37.34 1.57 0.00 0.00 421.15 29.51 37.36 37.04
Inventory Days 5.63 76.36 22.52 47.93 56.64 0.00 2.01 0.00 0.00
Days Payable 391.01 320.68 729.22 3,974.44 13,253.28 1,611.83
Cash Conversion Cycle -307.12 -206.97 -705.13 -3,926.52 -13,196.64 421.15 -1,580.31 37.36 37.04
Working Capital Days -1,437.41 -1,634.72 -1,490.33 -10,756.62 -19,392.61 -3,650.00 82.64 268.24 801.37
ROCE % -22.31% -34.09% -59.62% -12.82% -21.98% -7.41% 36.90% -4.27% 9.93% 11.12% 5.96% 14.78%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
30.76% 30.76% 30.77% 30.77% 30.78% 30.78% 30.78% 30.78% 30.78% 31.35% 31.35% 31.35%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.38%
0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.10% 0.10%
69.24% 69.23% 69.23% 69.22% 69.22% 69.23% 69.21% 69.23% 69.22% 68.65% 68.54% 68.18%
No. of Shareholders 1,81,5891,80,1991,79,4041,78,2741,77,7431,75,2221,71,9441,70,0791,69,2281,72,3381,71,2211,70,912

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents